Esperion Therapeutics

Esperion Therapeutics, Inc.
Company typePublic
Nasdaq: ESPR
Russell 2000 Component
IndustryPharmaceutical
Founded2008 (2008)
Founder
  • Dr. Roger Newton
HeadquartersAnn Arbor, Michigan
Key people
Sheldon Koenig (president and CEO)
  • US$269.1 million (2020)
Total assets
  • US$381.6 million (2020)
WebsiteEsperion.com
Footnotes / references
financial information: F-3, 4 

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.